FDA Remains Concerned About Plavix Heart Risk with Prilosec

Federal health regulators indicate that they are still concerned about the potential heart risks when Plavix is combined with Prilosec, despite a recent study that suggested the heartburn medication may not reduce the effectiveness of the blood thinner.

The FDA is planning to reiterate a public health advisory that was originally issued last year, warning that warned that Prilosec and other stomach acid reducers may interfere with Plavix, increasing the risk of heart attack, death and other injuries. The agency’s intentions were reported in a recent Wall Street Journal article and the reiterated warning has not yet been released.

Earlier this month a study published in the New England Journal of Medicine that found that side effects of Prilosec and Nexium did not appear to have any clinically significant impact on Plavix. The study contradicted the findings of a number of other studies, which have suggested that the use of the drugs reduces the effectiveness of the anti-clotting drug by about 50%.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

The latest study was funded by Cogentus Pharmaceuticals, which is trying to develop a product that combines Plavix with heartburn medication to make it easier on patients’ stomachs.

FDA officials told the Wall Street Journal that Cogent’s study was too small and used a time-release form of Prilosec that is not available to most patients. They said the FDA will reiterate the warning because they are afraid doctors will interpret the new study as meaning that it’s okay to use the Prilosec and Plavix together again.

Last year, the FDA required new warnings about Plavix heart risks when used with Prilosec, Nexium or other heartburn drugs that work by inhibiting the CYP2C19 enzyme. The FDA has said that this latest study could not provide conclusive results due to its small size. 

Plavix (clopidogrel) is a blood thinner that prevents blood platelets from sticking together to form clots. It is prescribed to prevent heart attacks, strokes and blood clotting when drug coated stents are used in patients with arteriosclerosis and in other at-risk patients. It is a blockbuster medication, generating annual sales of over $6 billion for Bristol Myers Squibb Co. and Sanofi-Aventis.

Prilosec (omeprazole) is a proton pump inhibitor used to reduce stomach acid, which is manufactured by AstraZeneca and available as a generic.

Prilosec and other stomach acid drugs are often prescribed along with Plavix to combat upset stomachs caused by gastrointestinal bleeding, a common Plavix side effect. The FDA indicates that Prilosec may actually inhibit the drug metabolizing enzyme in the body that normally would convert Plavix into its active form, which reduces its effectiveness, putting patients at risk of heart attack and stroke.

1 Comments

  • DennisOctober 8, 2011 at 9:58 pm

    What would you expect from a company who has it on their agenda to manufacture the combination drug?? HELLO!! It's like corporate America policing themselves................that's a catastrophic event within itself! And then to icing the cake, the FDA has numerous other studies suggesting otherwise! When will these drug companies catch on??? We have to start fining them MORE than the proceeds they[Show More]What would you expect from a company who has it on their agenda to manufacture the combination drug?? HELLO!! It's like corporate America policing themselves................that's a catastrophic event within itself! And then to icing the cake, the FDA has numerous other studies suggesting otherwise! When will these drug companies catch on??? We have to start fining them MORE than the proceeds they can aquire!! Anyone who can make billions and pay a measily couple million in fines and restitution................which would you choose??

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades
Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades (Posted 3 days ago)

After decades of medical research and reported Depo-Provera side effects, Pfizer should have known that its birth control shot increases the risks of meningioma brain tumors, yet failed to warn women or the medical community.

Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto
Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto (Posted 3 days ago)

Bayer and Monsanto prevailed in a Roundup lawsuit that went to trial in Philadelphia this week, after a jury found that exposure to the herbicide did not cause a man to develop non-Hodgkin's lymphoma.